Citigroup (C)
(Delayed Data from NYSE)
$78.48 USD
-1.13 (-1.42%)
Updated Feb 4, 2025 04:03 PM ET
After-Market: $78.36 -0.12 (-0.15%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
C 78.48 -1.13(-1.42%)
Will C be a Portfolio Killer in February?
Zacks Investment Research is releasing its prediction for C based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for C
BlackRock Mulls Over Launching an Office in Kuwait, Expanding Presence
How to Play BAC Stock as Tariffs Create Ambiguity Over Rate Cuts?
C: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Citigroup (C) is a Top Dividend Stock for Your Portfolio
Is Most-Watched Stock Citigroup Inc. (C) Worth Betting on Now?
The Zacks Rank Explained: How to Find Strong Buy Finance Stocks
Other News for C
10 Financials Stocks Whale Activity In Today's Session
China retaliates with tariffs on U.S., Merck falls after earnings: Morning Buzz
China retaliates with tariffs on U.S., Merck falls after earnings: Morning Buzz
Citigroup Unusual Options Activity For February 04
See Which Of The Latest 13F Filers Holds Citigroup